bpc-157 not approved by fda statement for human use compounding panel backs easier access to peptides FDA Discusses Peptide Bulk Substances – fda bpc-157 not approved human

Common side effects include: Injection site reactions pain, redness, or swelling at the injection site Mild diarrhoea or gastrointestinal upset usually transient Skin reactions itching or rash (uncommon) Hypokalaemia rare, occurring when severe megaloblastic anaemia is corrected rapidly Serious adverse effects are extremely rare but may include anaphylaxis in hypersensitive individuals

In animal studies, BPC-157 has shown potential for accelerating tendon healing, reducing inflammation, supporting gut lining repair, and protecting organs

While more studies are needed, its potential impact on brain function and nervous system repair is promising

It's best to follow their directions and use this article as a refresher